A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor - Concepedia

Concepedia

Publication | Open Access

A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor

DOI Full Paper Access

62

Citations

16

References

2021

Year

Ibiayi Dagogo‐Jack, Philicia Moonsamy, Justin F. Gainor, Jochen K. Lennerz, Zofia Piotrowska, Inga T. Lennes, Lecia V. Sequist, Alice T. Shaw, Kelly Goodwin, Sara E. Stevens,

Journal of Thoracic Oncology

OncologyMedicineCancer ManagementMet InhibitorMetronomic TherapyBronchial NeoplasmMetronomic ChemotherapyCancer TreatmentPhase 2PharmacologyRadiation OncologyLung Cancer

References

	Year	Citations

Page 1

Page 1